Variant report

Variant	esv3322961
Chromosome Location	chr10:23480571-23483119
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:42)
CpG islands
(count:614)
Chromatin interactive
region (count:0)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:42 , 50 per page) page: 1

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr10:23481438-23481598	H1-hESC	embryonic stem cell:	n/a	n/a
2	CTBP2	chr10:23479936-23482481	H1-hESC	embryonic stem cell:	n/a	n/a
3	CTCF	chr10:23481705-23481880	H1-hESC	embryonic stem cell:	n/a	n/a
4	CTCF	chr10:23481680-23481830	HEK293	kidney:	n/a	n/a
5	CTCF	chr10:23481823-23481847	Fibrobl	skin:	n/a	n/a
6	CTCF	chr10:23481623-23481901	H1-hESC	embryonic stem cell:	n/a	n/a
7	CTCF	chr10:23481540-23481870	H1-hESC	embryonic stem cell:	n/a	n/a
8	CTCF	chr10:23481750-23481858	Pancreas_OC	pancreas:	n/a	n/a
9	CTCF	chr10:23481640-23481790	WERI-Rb-1	eye:	n/a	n/a
10	CTCF	chr10:23481680-23481830	WERI-Rb-1	eye:	n/a	n/a
11	CTCF	chr10:23481859-23481893	Fibrobl	skin:	n/a	n/a
12	E2F6	chr10:23480648-23481045	H1-hESC	embryonic stem cell:	n/a	n/a
13	E2F6	chr10:23481362-23482238	H1-hESC	embryonic stem cell:	n/a	n/a
14	E2F6	chr10:23480742-23481213	H1-hESC	embryonic stem cell:	n/a	chr10:23481163-23481172
15	E2F6	chr10:23481438-23482266	H1-hESC	embryonic stem cell:	n/a	n/a
16	EGR1	chr10:23481544-23481932	H1-hESC	embryonic stem cell:	n/a	n/a
17	GABPA	chr10:23480827-23481049	H1-hESC	embryonic stem cell:	n/a	chr10:23480925-23480934
18	GABPA	chr10:23481719-23482142	H1-hESC	embryonic stem cell:	n/a	n/a
19	HMGN3	chr10:23481340-23481424	K562	blood:	n/a	n/a
20	MAX	chr10:23481338-23482300	H1-hESC	embryonic stem cell:	n/a	chr10:23481373-23481383
21	MAX	chr10:23481800-23482091	H1-hESC	embryonic stem cell:	n/a	n/a
22	MAX	chr10:23481339-23482282	H1-hESC	embryonic stem cell:	n/a	chr10:23481373-23481383
23	MAX	chr10:23481762-23482074	ECC-1	luminal epithelium:	n/a	n/a
24	MAX	chr10:23480702-23481272	H1-hESC	embryonic stem cell:	n/a	n/a
25	NANOG	chr10:23481452-23481729	H1-hESC	embryonic stem cell:	n/a	n/a
26	POLR2A	chr10:23481693-23482311	H1-neurons	neurons:	n/a	n/a
27	POLR2A	chr10:23482201-23482974	H1-neurons	neurons:	n/a	n/a
28	POLR2A	chr10:23481766-23482197	H1-neurons	neurons:	n/a	n/a
29	POLR2A	chr10:23482347-23482937	H1-neurons	neurons:	n/a	n/a
30	RAD21	chr10:23481633-23481844	H1-hESC	embryonic stem cell:	n/a	n/a
31	RAD21	chr10:23481500-23482019	H1-hESC	embryonic stem cell:	n/a	n/a
32	RAD21	chr10:23481631-23481911	H1-hESC	embryonic stem cell:	n/a	n/a
33	SIN3A	chr10:23480853-23480942	H1-hESC	embryonic stem cell:	n/a	n/a
34	SIN3A	chr10:23481237-23481395	H1-hESC	embryonic stem cell:	n/a	n/a
35	SIN3A	chr10:23481860-23481865	H1-hESC	embryonic stem cell:	n/a	n/a
36	SUZ12	chr10:23479777-23482696	H1-hESC	embryonic stem cell:	n/a	n/a
37	SUZ12	chr10:23479864-23482543	NT2-D1	testis:	n/a	n/a
38	TBP	chr10:23481678-23481963	H1-hESC	embryonic stem cell:	n/a	n/a
39	TBP	chr10:23482226-23482341	H1-hESC	embryonic stem cell:	n/a	n/a
40	ZNF143	chr10:23481289-23481641	H1-hESC	embryonic stem cell:	n/a	n/a
41	ZNF143	chr10:23480835-23480967	H1-hESC	embryonic stem cell:	n/a	chr10:23480911-23480921
42	ZNF263	chr10:23481214-23482132	HEK293-T-REx	kidney:	n/a	n/a

(count:614 , 50 per page) page: 1 2 3 4 5 6 7 ... 13

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr10:23481421-23481471	Caco-2	colon:	n/a
2	chr10:23481176-23481226	HL-60	blood:	n/a
3	chr10:23481389-23481439	H1-hESC	embryonic stem cell:	embryo
4	chr10:23482255-23482305	AG10803	skin:	n/a
5	chr10:23481421-23481471	Caco-2	colon:	n/a
6	chr10:23481176-23481226	HL-60	blood:	n/a
7	chr10:23481389-23481439	H1-hESC	embryonic stem cell:	embryo
8	chr10:23482255-23482305	AG10803	skin:	n/a
9	chr10:23481594-23481644	Hela-S3	cervix:	n/a
10	chr10:23481786-23481836	GM12891	blood:	n/a
11	chr10:23481389-23481439	HEEpiC	esophagus:	n/a
12	chr10:23480730-23480780	GM12892	blood:	n/a
13	chr10:23481594-23481644	PANC-1	pancreas:	n/a
14	chr10:23481594-23481644	SK-N-MC	brain:	n/a
15	chr10:23482255-23482305	AG09319	gingival:	n/a
16	chr10:23481176-23481226	HMEC	breast:	n/a
17	chr10:23481385-23481435	SKMC	muscle:	n/a
18	chr10:23482255-23482305	AG04449	skin:	fetal
19	chr10:23481385-23481435	A549	lung:	n/a
20	chr10:23481385-23481435	GM19239	blood:	n/a
21	chr10:23482255-23482305	SAEC	small airway:	n/a
22	chr10:23481594-23481644	HepG2	liver:	n/a
23	chr10:23481776-23481826	CMK	blood:	n/a
24	chr10:23481421-23481471	Jurkat	blood:	n/a
25	chr10:23481385-23481435	ProgFib	skin:	n/a
26	chr10:23481776-23481826	SK-N-MC	brain:	n/a
27	chr10:23482255-23482305	MCF-7	breast:	n/a
28	chr10:23480803-23480853	HRCEpiC	kidney:	n/a
29	chr10:23481776-23481826	NT2-D1	testis:	n/a
30	chr10:23481389-23481439	SK-N-SH_RA	brain:	n/a
31	chr10:23481421-23481471	Hepatocyte	liver:	n/a
32	chr10:23480803-23480853	ProgFib	skin:	n/a
33	chr10:23481389-23481439	PANC-1	pancreas:	n/a
34	chr10:23481594-23481644	HAEpiC	amniotic membrane:	n/a
35	chr10:23481389-23481439	NB4	blood:	n/a
36	chr10:23481786-23481836	Caco-2	colon:	n/a
37	chr10:23481594-23481644	T-47D	breast:	n/a
38	chr10:23480803-23480853	MCF10A-Er-Src	breast:	n/a
39	chr10:23481385-23481435	HRCEpiC	kidney:	n/a
40	chr10:23481786-23481836	HepG2	liver:	n/a
41	chr10:23480730-23480780	HCT-116	colon:	n/a
42	chr10:23481176-23481226	AG04449	skin:	fetal
43	chr10:23481776-23481826	PrEC	prostate:	n/a
44	chr10:23481389-23481439	HUVEC	blood vessel:	n/a
45	chr10:23481385-23481435	NHBE	bronchial:	n/a
46	chr10:23480803-23480853	PANC-1	pancreas:	n/a
47	chr10:23482255-23482305	SK-N-SH_RA	brain:	n/a
48	chr10:23480803-23480853	RPTEC	kidney:	n/a
49	chr10:23482255-23482305	K562	blood:	n/a
50	chr10:23481421-23481471	NT2-D1	testis:	n/a

No data

Variant related genes	Relation type
PTF1A	TF binding region
PTF1A	CpG island

Extended variants
information (count: 120 )
Associated
traits (count: 37 )

Variant overlapped rSNPs/rCNVs (count:120 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs371759002	chr10:23480578-23480579	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
2	rs571029796	chr10:23480597-23480598	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs368463823	chr10:23480600-23480601	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs140109150	chr10:23480601-23480602	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs550156968	chr10:23480633-23480634	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs375998020	chr10:23480693-23480694	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs532802495	chr10:23480698-23480699	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs370084376	chr10:23480709-23480710	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs570055820	chr10:23480729-23480730	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs114007003	chr10:23480828-23480829	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
11	rs555873493	chr10:23480841-23480842	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
12	rs375045074	chr10:23480867-23480868	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs112407216	chr10:23480904-23480905	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs371352139	chr10:23480928-23480929	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs554053970	chr10:23480955-23480956	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs577025631	chr10:23481012-23481013	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs185209033	chr10:23481043-23481044	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs555790897	chr10:23481075-23481076	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs575613349	chr10:23481095-23481096	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs541560232	chr10:23481113-23481114	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs145216233	chr10:23481121-23481122	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs572623181	chr10:23481139-23481140	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs541220119	chr10:23481140-23481141	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs564810256	chr10:23481145-23481146	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs112034203	chr10:23481148-23481149	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs533495117	chr10:23481153-23481154	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs550492547	chr10:23481169-23481170	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs563700905	chr10:23481181-23481182	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
29	rs529287944	chr10:23481192-23481193	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
30	rs114630888	chr10:23481217-23481218	Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
31	rs566009852	chr10:23481248-23481249	Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs533992460	chr10:23481263-23481264	Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs547318221	chr10:23481272-23481273	Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs570624412	chr10:23481295-23481296	Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs377316075	chr10:23481327-23481328	Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs556026337	chr10:23481337-23481338	Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs575648203	chr10:23481345-23481346	Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs535055490	chr10:23481380-23481381	Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs555444660	chr10:23481384-23481385	Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs572003380	chr10:23481386-23481387	Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs541109338	chr10:23481388-23481389	Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs368811054	chr10:23481423-23481424	Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs371934937	chr10:23481424-23481425	Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs199869734	chr10:23481436-23481437	Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs201994193	chr10:23481437-23481438	Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs200997535	chr10:23481454-23481455	Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
47	rs146089816	chr10:23481467-23481468	Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
48	rs200273790	chr10:23481481-23481482	Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
49	rs140097468	chr10:23481503-23481504	Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
50	rs376887768	chr10:23481534-23481535	Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Enhancers Active TSS Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:37)

Disease	PMID	Source
Breast cancer	17133270	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Breast cancer	17603634	CNVD
Endometrial cancer	22040021	CNVD
Glioblastoma multiforme	21080181	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Phyllodes tumor	17334353	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Pancreatic endocrine tumor	17639061	CNVD
Gastric cancer	17908304	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Medulloblastoma	21979893	CNVD
Melanoma	18172304	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
Lung cancer	18438408	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Ewing''s sarcoma	17952124	CNVD
Oral cancer	21386901	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21858162	CNVD
Acute lymphoblastic leukemia	20724749	CNVD
Autism	22495311	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
T-cell lymphomas	19863542	CNVD
Esophageal cancer	21851588	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	21364760	CNVD
Acute lymphoblastic leukemia	18458336	CNVD
Behavioral abnormalities	21522184	CNVD
Dysmorphic features	21522184	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Glioblastoma multiforme	22286061	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD

Chromatin state (count:162 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr10:23479200-23481600	Bivalent Enhancer	H9 Derived Neuron Cultured Cells	ES cell derived
2	chr10:23479200-23483400	Active TSS	Pancreas	Pancrea
3	chr10:23479400-23480600	Bivalent Enhancer	H1 Cell Line	embryonic stem cell
4	chr10:23479600-23480800	Bivalent Enhancer	iPS-20b Cell Line	embryonic stem cell
5	chr10:23479600-23481400	Bivalent Enhancer	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
6	chr10:23479800-23480800	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin03	Skin
7	chr10:23479800-23482600	Bivalent/Poised TSS	ES-I3 Cell Line	embryonic stem cell
8	chr10:23480000-23480600	Bivalent Enhancer	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
9	chr10:23480000-23481000	Bivalent Enhancer	Ganglion Eminence derived primary cultured neurospheres	brain
10	chr10:23480000-23481600	Bivalent Enhancer	Cortex derived primary cultured neurospheres	brain
11	chr10:23480000-23481800	Bivalent Enhancer	Fetal Brain Male	brain
12	chr10:23480200-23480600	Bivalent Enhancer	iPS-18 Cell Line	embryonic stem cell
13	chr10:23480200-23480800	Bivalent Enhancer	Primary hematopoietic stem cells	blood
14	chr10:23480200-23481200	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
15	chr10:23480200-23482400	Bivalent/Poised TSS	HUES6 Cell Line	embryonic stem cell
16	chr10:23480200-23482600	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
17	chr10:23480200-23484400	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
18	chr10:23480400-23480600	Flanking Bivalent TSS/Enh	ES-UCSF4 Cell Line	embryonic stem cell
19	chr10:23480400-23480600	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin01	Skin
20	chr10:23480400-23480600	Bivalent Enhancer	Brain Cingulate Gyrus	brain
21	chr10:23480400-23480600	Bivalent Enhancer	Skeletal Muscle Male	skeletal muscle
22	chr10:23480400-23480800	Flanking Bivalent TSS/Enh	iPS DF 19.11 Cell Line	embryonic stem cell
23	chr10:23480400-23480800	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
24	chr10:23480400-23480800	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
25	chr10:23480400-23480800	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin01	Skin
26	chr10:23480400-23480800	Bivalent Enhancer	Brain Germinal Matrix	brain
27	chr10:23480400-23480800	Flanking Bivalent TSS/Enh	Fetal Brain Female	brain
28	chr10:23480400-23480800	Bivalent/Poised TSS	Pancreatic Islets	Pancreatic Islet
29	chr10:23480400-23480800	Bivalent Enhancer	Fetal Stomach	stomach
30	chr10:23480400-23481000	Bivalent Enhancer	Right Ventricle	heart
31	chr10:23480400-23481400	Bivalent Enhancer	Duodenum Smooth Muscle	Duodenum
32	chr10:23480400-23481400	Bivalent Enhancer	Fetal Muscle Trunk	muscle
33	chr10:23480400-23481800	Bivalent/Poised TSS	HUES48 Cell Line	embryonic stem cell
34	chr10:23480400-23482400	Bivalent/Poised TSS	H9 Cell Line	embryonic stem cell
35	chr10:23480400-23482400	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
36	chr10:23480400-23482600	Bivalent Enhancer	H1 Derived Mesenchymal Stem Cells	ES cell derived
37	chr10:23480600-23480800	Flanking Bivalent TSS/Enh	H1 Cell Line	embryonic stem cell
38	chr10:23480600-23480800	Flanking Bivalent TSS/Enh	iPS-18 Cell Line	embryonic stem cell
39	chr10:23480600-23480800	Flanking Bivalent TSS/Enh	iPS DF 6.9 Cell Line	embryonic stem cell
40	chr10:23480600-23480800	Bivalent Enhancer	ES-UCSF4 Cell Line	embryonic stem cell
41	chr10:23480600-23480800	Bivalent Enhancer	Brain Substantia Nigra	brain
42	chr10:23480600-23480800	Bivalent Enhancer	Psoas Muscle	Psoas
43	chr10:23480600-23481000	Bivalent Enhancer	Liver	Liver
44	chr10:23480600-23481600	Bivalent Enhancer	Colonic Mucosa	Colon
45	chr10:23480600-23481800	Bivalent Enhancer	Placenta Amnion	Placenta Amnion
46	chr10:23480600-23482200	Bivalent Enhancer	Spleen	Spleen
47	chr10:23480800-23481000	Flanking Bivalent TSS/Enh	iPS-20b Cell Line	embryonic stem cell
48	chr10:23480800-23481000	Flanking Active TSS	iPS DF 19.11 Cell Line	embryonic stem cell
49	chr10:23480800-23481000	Flanking Bivalent TSS/Enh	ES-UCSF4 Cell Line	embryonic stem cell
50	chr10:23480800-23481000	Flanking Bivalent TSS/Enh	Primary hematopoietic stem cells	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links